- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03943771
Effect on Pre-operative Anxiety of a Personalized Three-dimensional Kidney Model Prior to Nephron-sparing Surgery for Renal Tumor. (R3DP-A)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Announcement of serious illnesses and especially cancerous diseases has major impacts on one's psychological field. Need of surgery can create even other fears due to its unknown nature. Use of tools to decrease anxiety and enhance understanding prior to surgery is a key point in comprehensive care that is way not enough promoted for now. In the field of surgery, available methods to deal with pre-operative anxiety are massively represented by anxiolytics drugs, only few other devices were evaluated.
Technological development in healthcare has seen the rising of three-dimensional media, especially in surgery, for procedure planning. There is no doubt that this tool is effective in helping surgeons regarding the studies published within the past few years but there is no such evidence concerning the benefit for patients. Some authors report improvement of patients understanding and great satisfaction referring to the usefulness of this tool. But none of these papers evaluated anxiety.
The goal of our research is to measure the effect of a personalized three-dimensional model of patients' kidney on pre-operative anxiety.
For this purpose investigators will randomly assign a total of 66 patients planned to have a nephron-sparing surgery for kidney tumor in 3 different groups. Inside the 2 interventional groups, patients' kidneys will be modelized in three dimensions, one group will then be 3D-printed.
The third group will be control with usual preoperative information. The day before surgery, 3D models will be presented to their respective owner. All patients will have to complete a survey evaluating their anxiety level and also their understanding of renal anatomy and surgical procedure.
Study Type
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Bordeaux, France, 33076
- CHU de Bordeaux
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Consecutive patients presenting with renal tumor allowing a nephron-sparing surgery
- Participating in UroCCR database
- Having a contrast abdominal scanner prior to surgery
- Owing social insurance contract
- Inpatient surgery
Exclusion Criteria:
- Unable to give informed consent
- No contrast scanner
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Virtual modelization group
Patients having their kidney modelized in three dimensions on a software
|
The day before surgery, all the patients will be visited by a member of the investigator team for preoperative consultation and will be given a questionnaire evaluating their anxiety based on STAI and VAS scores. The two experimental groups will be offered their renal modelization to be manipulated (virtually or physically) before the questionnaire. A second survey assessing basic renal anatomy and surgery understanding will also be completed by the patients. Anxiolytics prescription prior to surgery will be collected inside the medical file. |
|
Experimental: Printed modelization group
Patients having their kidney modelized and printed in three dimensions
|
The day before surgery, all the patients will be visited by a member of the investigator team for preoperative consultation and will be given a questionnaire evaluating their anxiety based on STAI and VAS scores. The two experimental groups will be offered their renal modelization to be manipulated (virtually or physically) before the questionnaire. A second survey assessing basic renal anatomy and surgery understanding will also be completed by the patients. Anxiolytics prescription prior to surgery will be collected inside the medical file. |
|
Sham Comparator: Control group
No kidney model
|
The day before surgery, all the patients will be visited by a member of the investigator team for preoperative consultation and will be given a questionnaire evaluating their anxiety based on STAI and VAS scores. The two experimental groups will be offered their renal modelization to be manipulated (virtually or physically) before the questionnaire. A second survey assessing basic renal anatomy and surgery understanding will also be completed by the patients. Anxiolytics prescription prior to surgery will be collected inside the medical file. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
State-anxiety score of the State-Trait Anxiety Inventory (STAI) questionnaire
Time Frame: The day before renal surgery, up to 1 month after inclusion
|
Min : 20 = few anxiety Max : 80 = severe anxiety
|
The day before renal surgery, up to 1 month after inclusion
|
|
Visual Analog Scale (VAS) score for anxiety
Time Frame: The day before renal surgery, up to 1 month after inclusion
|
Min : 0 = no anxiety Max : 10 = maximum anxiety
|
The day before renal surgery, up to 1 month after inclusion
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Renal anatomy and surgical strategies questionnaire score
Time Frame: The day before renal surgery, up to 1 month after inclusion
|
Renal anatomy : min/max = 0/13, higher values represent a better understanding Surgical strategies : min/max = 0/7, higher values represent a better understanding
|
The day before renal surgery, up to 1 month after inclusion
|
|
Anxiolytics prescription before surgery
Time Frame: The day before renal surgery, up to 1 month after inclusion
|
The day before renal surgery, up to 1 month after inclusion
|
|
|
Pain numeric scale score
Time Frame: The day after renal surgery, up to 1 month after inclusion
|
Min : 0 = no pain Max : 10 = maximum pain
|
The day after renal surgery, up to 1 month after inclusion
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CHUBX 2017/58
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Kidney Neoplasms
-
Philips HealthcareWithdrawnKidney TumorsUnited States
-
St. Petersburg State Pavlov Medical UniversitySaint Petersburg State University, RussiaCompleted
-
Tianjin Medical University Second HospitalRecruiting
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedKidney TumorUnited States
-
Tianjin Medical University Second HospitalRecruiting
-
Thomas MuellerUnknownKidney Neoplasms | Adult Polycystic Kidney Disease | Kidney DysfunctionSwitzerland
-
Yale UniversityCompleted
-
Intuitive SurgicalCompleted
-
Stanford UniversityNational Cancer Institute (NCI)WithdrawnProstate Cancer | Bladder Cancer | Kidney Tumor
-
University of Texas Southwestern Medical CenterCompletedKidney Cancer | Kidney Cancer Metastatic | Kidney Cancer, Stage IVUnited States
Clinical Trials on Anxiety, renal anatomy and surgery questionnaires
-
Indiana Kidney Stone InstituteUniversity of Chicago; Indiana University School of MedicineActive, not recruitingHyperparathyroidism | Cystinuria | Renal Calculi | Hypercalciuria | NephrocalcinosisUnited States
-
CHU de ReimsCompleted
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedIntraocular MelanomaUnited States
-
Nazife Begüm KARANCompletedDental Anxiety | Sedative; Anxiety DisorderTurkey
-
Weill Medical College of Cornell UniversityWithdrawnIschemia | Stress, MentalUnited States
-
Connecticut Children's Medical CenterCompletedInflammatory Bowel DiseaseUnited States
-
Rennes University HospitalCompletedAnalgesia | Pain ManagementFrance, Lebanon
-
Ruijin HospitalRecruitingHypertension | Retroperitoneal DiseaseChina
-
Centro Cardiologico MonzinoActive, not recruitingInflammation | Sleep Disorder | Hemostatic Disorder | Shift-Work Related Sleep DisturbanceItaly
-
Assistance Publique - Hôpitaux de ParisCompletedPsychiatric Disorders | Behçet's DiseaseFrance